News
0
Roche revealed strong data on its cancer immunotherapy Tecentriq in combination with chemotherapy in the first-line treatment of previously...
0
Japanese pharma firm Takeda has announced that the gut-selective biologic vedolizumab when taken as a subcutaneous (SC) injection, proved...
0
Janssen has revealed new long-term data for its IL-23 inhibitor Tremfya (guselkumab) in moderate to severe plaque psoriasis, demonstrating skin...
0
American pharma firm Bristol-Myers Squibb have announced that more than 53% of patients with advanced melanoma, who were treated with Opdivo in...
Features
“It really is about having a dream and figuring out how to go about accomplishing that dream”
Featured Appointment
Civica Rx, a new not-for-profit generic drug company aimed at reducing the price of lifesaving medicines, has appointed former Amgen Chief Quality...
Service Company News
Featured Event
27/11/2018 - 29/11/2018 -
Barcelona,
